Comparison of Risk Factors for the Competing Risks of Coronary Heart Disease, Stroke, and Venous Thromboembolism
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation1998;97:1837–47.
Wolf PA, D'Agostino RB, Belanger AM, et al. Probability of stroke: a risk profile from the Framingham Study. Stroke1991;3:312–18.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA2001;285:2486–97.
Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA2003;289:2560–72.
Kannel WB, D'Agostino RB, Sullivan L, et al. Concept and usefulness of cardiovascular risk profiles. Am Heart J2004;148:16–26.
Stokes J, Kannel WB, Wolf PA, et al. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation1987;75(suppl V):V65–73.
Glynn RJ, Rosner B. Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol2004;57:113–22.
Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med2003;348:1435–41.
Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA1997;277:642–5.
Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Intern Med2000;132:689–96.
Hansson PO, Eriksson H, Welin L, et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: “the study of men born in 1913.” Arch Intern Med1999;159:1886–90.
Tsai AW, Cushman M, Rosamond W, et al. Cardiovascular risk factors and venous thromboembolism incidence. Arch Intern Med2002;162:1182–9.
Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med.1989;321:129–35.
Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med1996;334:1145–9.
Hebert PR, Rich-Edwards JW, Ridker PM, et al. Height and incidence of cardiovascular disease in male physicians. Circulation1993;88:1437–43.
Glynn RJ, L'Italien GJ, Sesso HD, et al. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension2002;39:105–10.
Klag MJ, He J, Mead LA, et al. Validity of physicians' self-reports of cardiovascular disease risk factors. Ann Epidemiol1993;3:442–7.
World Health Organization. Ischemic heart disease registers: report of the Fifth Working Group, including a second revision of the operating protocol. Copenhagen, Denmark, April 26–29, 1971. Copenhagen, Denmark: World Health Organization, Regional Office for Europe, 1971.
Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med1993;12:737–51.
Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol1997;145:72–80.
Lee EW, Wei LJ, Amato DJ. Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In: Klein JP, Goel PK, eds. Survival analysis: state of the art. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1992;237–47.
Schoenfeld D. Chi-squared goodness-of-fit tests for the propor tional hazards regression model. Biometrics1980;67:145–53.